Introduction: Comparative effectiveness research (CER) often fails to create quality improvement since implementation of CER results in clinical practice is lacking. Claims-based Audit & Feedback (A&F) provides a resource efficient tool to stimulate implementation, but it is unknown whether medical professionals accept claims-based A&F in the context of CER. Therefore, in this study, we developed claims-based indicators using a cocreation approach and evaluated medical professionals' perception regarding the validity and acceptability of these indicators.

Methods: Between July 2019 and November 2021, we used a cocreation approach with medical experts to develop claims-based indicators for six CER trials. The aim is to use the indicators for group level feedback on implementation of CER results to medical professionals across all healthcare providers in the Netherlands. To build the indicators, we used the most recent available Dutch national healthcare-related claims data of the year 2017. The cocreation process consisted of the following steps: (1) defining the target indicator, (2) selecting relevant claims codes, (3) testing feasibility of the indicators using Dutch claims data, (4) discussing results of feasibility testing and (5) defining the final indicators and reflecting on the acceptability of the indicators for feedback on implementation of CER results by the experts.

Results: Claims-based indicators could not perfectly reflect the CER population for any of the six CER trials. However, the cocreation process did lead to a final indicator that medical experts found acceptable in four of six cases. Recommendations of medical experts for improving claims-based indicators included: select patients with minimal over- or underestimation of the CER population, use proxies to identify patients, determine incidence rather than prevalence for chronic conditions and use data linkage with diagnostic test results.

Conclusion: A cocreation approach was a successful way to develop claims-based indicators on implementation of CER results, which were imperfect, but in some cases still acceptable as feedback to medical experts. Thus, for certain topics, claims data may provide a resource efficient data source for A&F interventions aiming to implement CER trials.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11887289PMC
http://dx.doi.org/10.1136/bmjoq-2023-002542DOI Listing

Publication Analysis

Top Keywords

claims-based indicators
24
implementation cer
16
medical experts
16
develop claims-based
12
feedback implementation
12
cocreation approach
12
cer trials
12
claims data
12
indicators
11
cer
11

Similar Publications

Introduction: Comparative effectiveness research (CER) often fails to create quality improvement since implementation of CER results in clinical practice is lacking. Claims-based Audit & Feedback (A&F) provides a resource efficient tool to stimulate implementation, but it is unknown whether medical professionals accept claims-based A&F in the context of CER. Therefore, in this study, we developed claims-based indicators using a cocreation approach and evaluated medical professionals' perception regarding the validity and acceptability of these indicators.

View Article and Find Full Text PDF

Importance: Considerable efforts have been dedicated to improving the quality of end-of-life care among patients with advanced cancer in the past decade. Whether the quality has shifted in response to these efforts remains unknown.

Objective: To examine contemporary patterns of end-of-life care among patients with advanced cancer.

View Article and Find Full Text PDF

Rationale: Robust COVID-19 outcomes classification is important for ongoing epidemiology research on acute and post-acute COVID-19 conditions. Protocolized medical record review is an established method to validate endpoints for clinical trials and cardiovascular epidemiology cohorts; however, a protocol to adjudicate hospitalizations for COVID-19 among epidemiology cohorts was lacking.

Objectives: We developed a protocol to ascertain and adjudicate hospitalized COVID-19 across a meta-cohort of 14 US prospective cohort studies.

View Article and Find Full Text PDF

Background: Pregnant people are at risk of severe coronavirus disease 2019 (COVID-19) and associated complications. While withholding treatment from pregnant patients is not recommended, little is known about the frequency of antiviral medication use during pregnancy.

Methods: Using Medicaid and commercial insurance databases, we constructed a national claims-based cohort study of pregnant, recently pregnant, and nonpregnant female patients 18-49 years old with an outpatient diagnosis of COVID-19 between 21 December 2021 and 30 September 2022.

View Article and Find Full Text PDF

Background: Frailty is associated with poor outcomes in older adults with cancer. Several efforts have been made to assess frailty using the administrative claims data based on the number of clinical diagnosis codes, yet the literature reporting on this is scarce. This study aimed to evaluate the impact of frailty measures using administrative databases in Japan.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!